Retraction

FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer

Citations (7)

7
Total Citations
3
Post-Retraction
(42.9%)
3
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
3 Within 1 year
0 After 2+ years
51 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Dissecting multifunctional roles of forkhead box transcription factor D1 in cancers
Lin Cheng, Haixu Yan, Yang Liu et al. (5 authors)
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Published: Sep 2023
3 citations
51 days after retraction
Prognostic and clinicopathological significance of FOXD1 in various cancers: a meta and bioinformation analysis
Xiaohan Liu, Shengyun Min, Qin Zhang et al. (7 authors)
Future Science OA Open Access
Published: Sep 2023
5 citations
43 days after retraction
miR-30e-5p-mediated FOXD1 promotes cell proliferation by blocking cellular senescence and apoptosis through p21/CDK2/Rb signaling in head and neck carcinoma
Tong Wu, Zhongyuan Yang, Weichao Chen et al. (11 authors)
Cell Death Discovery Open Access
Published: Aug 2023
8 citations
15 days after retraction
An inhibitor of claudin-5 interactions, M01, alleviates neuroinflammation and vasogenic edema after blood–spinal cord barrier dysfunction
Jin Huang, Yang Cao, Sheng Hsiung Chang
Neuroreport
Published: May 2023
3 citations
67 days before retraction
BMSC-Derived Exosomes Carrying lncRNA-ZFAS1 Alleviate Pulmonary Ischemia/Reperfusion Injury by UPF1-Mediated mRNA Decay of FOXD1
Cao Gao, Yan-Jie Xu, Zhixiu Meng et al. (6 authors)
Molecular Neurobiology
Published: Jan 2023
13 citations
189 days before retraction
Retracted: FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer
Journal of Healthcare Engineering
Journal of Healthcare Engineering Open Access
Published: Jan 2023
206 days before retraction
Quick Stats
Total Citations: 12
Years Since Retraction: 2.3 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Alpinumisoflavone radiosensitizes esophageal squamous cell …
Biomedicine & Pharmacotherapy • 34 citations
Evaluation of the treatment strategies on patient-derived x…
European Journal of Pharmacology • 6 citations
Enhanced anticancer potency of doxorubicin in combination w…
Journal of Biochemical and Molecular Toxicology • 50 citations
Exploring cytotoxicity of cordycepin loaded nanovesicles ag…
Biomedicine & Pharmacotherapy • 6 citations